BACK TO ALL STUDIES

Fort Bragg, NC: Bragg Beneficiary Community Seroprevalance Study

PRIMARY OBJECTIVE(s)

To determine the impact of the current Coronavirus Disease 2019 (COVID-19) on the Fort Bragg and Womack Army Medical Center beneficiary population through the use of serological assays for SARS-CoV-2.

PRINCIPAL INVESTIGATOR(S)

Sammy Choi

CONTACT
Sammy Choi
young.s.choi.civ@mail.mil
TREATMENT/CLINICAL & LAB INVESTIGATION

No treatment. SARS-CoV-2 antibody testing.

POPULATION
Fort Bragg and WAMC beneficiaries, adult, active duty, retired and dependent
FULL NAME OF DIAGNOSTIC TEST
Lab Used for Diagnostic Test
Full Name of Serology/Antibody Test

Roche Elecsys Anti-SARS-CoV-2 assay on the Roche Cobas e System of IgG and IgM

Lab Used for Serology/Antibody Test
Womack Army Medical Center, Fort Bragg, NC
Want more information about this study?
study website